Viscom-Q1 shortfall – order momentum points to H2e inflection-05/18/2026

Research evidence excerpt

Viscom-Q1 shortfall – order momentum points to H2e inflection-05/18/2026

search” on the front page, Pareto “Not Rated” A recommendation, target price, and/or financial forecast have not

Securities has entered into an agreement with the company about the preparation of research been disclosed. This may be due to legal, regulatory, or policy

reports and receives compensation from the company for this service. Sponsored research is constraints, or where Pareto Securities Research lacks sufficient

prepared by the Research Department of Pareto Securities without any instruction rights by the fundamental information to rate the financial instrument. The previous

company. Sponsored research is however commissioned for and paid by the company and recommendation and, if applicable, the target price, are no longer valid

such material is considered by Pareto Securities to qualify as an acceptable minor non- and should not be relied upon.

monetary benefit according to the EU MiFID II Directive.

Basis and methods for assessment Analysts Certification

Opinions and price targets are based on one or more methods of valuation, for instance cash The research analyst(s) whose name(s) appear on research reports prepared by Pareto

flow analysis, use of multiples, behavioral technical analyses of underlying market movements Securities Research certify that: (i) all of the views expressed in the research report accurately

in combination with considerations of the market situation and the time horizon. Key reflect their personal views about the subject security or issuer, and (ii) no part of the research

assumptions of forecasts, price targets and projections in research cited or reproduced appear analysts’ compensation was, is, or will be directly or indirectly related to the specific